Skip to Content
S22 - Scientific symposium sponsored by Bayer: Beyonttra: A new chapter in ATTR-CM management
Symposium
Location: Room Folon - 30/01/2026, 10:20 - 30/01/2026, 11:35 (Europe/Brussels) (1 hour 15 minutes)
Moderators:
Frank  Timmermans - UZ Gent
Anne-Catherine Pouleur -  Cliniques universitaires St-Luc, Brussels 

Speakers: 

Prof. Dr. Diana Bonderman is cardiologist at the Klinik Favoriten in Vienna, Austria. Her expertise focuses on heart failure, pulmonary hypertension, and ATTR cardiomyopathy. Dr. Bonderman is particularly known for developing innovative treatment approaches for pulmonary vascular diseases and ATTR cardiomyopathy. Her ongoing academic research aims to enhance our understanding of these conditions and improve patient outcomes, especially in heart failure and ATTR Cardiomyopathy cases.




Prof. Dr. Antoine Bondue is Head of the Cardiology Department at HUB Erasme Hospital in Brussels, President of the Belgian Cardiac League, and President of the Belgian Council of Cardiovascular Genomics. He is a member of the European Society of Cardiology (ESC) and a member of the European Council of Cardiovascular Genomics. Professor Bondue specializes in cardiomyopathies, cardiac amyloidosis, inherited cardiac conditions, and neurodegenerative diseases.


Dr. Matthias Dupont is a leading specialist in heart failure, cardiac myopathies, cardiac intensive care and pulmonary hypertension. He serves as the Head of the Cardiology Department at Ziekenhuis Oost Limburg in Genk. Dr. Dupont is also a member and past president of the Belgian Working Group of Heart Failure (BWGHF).